Skip to main content



Local Cdiff information for Washington DC

Washington DC

Learn about C. diff providers, regulation, clinical trials, and advocacy efforts in Washington DC.



Local Cdiff information for Washington DC

Washington DC

Learn about C. diff providers, regulation, clinical trials, and advocacy efforts in Washington DC.

Providers

Dr. Matthew J. Copeland, DO

Medstar Geogetown University Hospital
3800 Reservoir Road Northwest
Washington, DC 20007
202.444.0086
FMT Provider: No
VISIT WEBSITE >

Regulation

C. diff Infections

Total Reported Cases: 277
Hospital Onset: 277
Community Onset: Not reported
Related Deaths: Not reported

Available Reports

Annual Progress based on SIR: 0.66
CDC STATE PROGRESS REPORT >
STATE REPORTING >

State Reporting Laws

Data Submission Required: No
Data Publicly Available: No
Data Validated: Yes
Facility-specific Data Publicly Reported: No
LTC Facility Submission Required: No
LTC Facility Data Publicly Reported: No
Law/Regulation: Not available
STATUTE >

State Contact

Kenan Zamore, MPH
Senior Research Epidemiologist
DC Department of Health
Government of the District of Columbia
899 N Capitol St, Suite 582
Washington, 20002
(202) 727-3616
(202) 442-8060
EMAIL KENAN ZAMORE, MPH >

CLINICAL TRIALS

FMT National Registry

Official Title: Fecal Microbiota Transplant National Registry
Trial No. NCT03325855
Type: Observational
Recruitment: Recruiting
Sponsor: American Gastroenterological Association
Contact: Sonya Serra, MSc
301-941-2616
EMAIL
Gender: All
Age: All ages

RESTORATiVE303

Official Title: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Trial No. NCT06237452
Type: Interventional
Recruitment: Recruiting
Sponsor: Vedanta Biosciences, Inc
Contact: Mary Garfield
EMAIL >
Gender: All
Age: 12 Years and older
Vedanta Biosciences has teamed up with Science37 to provide a site-less, decentralized approach. This means the study can be done remotely and the product comes to you, in your home. This allows applicants who are not near a study site or unable to travel to participate and receive treatment. You can sign up for the decentralized study here.